Promising prostate cancer combo trial pulled before it even started
NCT ID NCT06881823
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 28 times
Summary
This study aimed to test two targeted radiation drugs (AAA602 and AAA802) given before surgery for men with high-risk prostate cancer that had spread to nearby lymph nodes. The goal was to see if the drugs could shrink the cancer and delay its return after the prostate and lymph nodes were removed. However, the trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.